CTRI/2024/07/070332尚未招募Unknown
Assessment of efficacy of early introduction of ACE (angiotensin converting enzyme) inhibitors in treatment of congestive heart failure in children with medium sized ventricular septal defects: a single center open label randomized trial - NI
All India Institute of Medical Sciences, Patna0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All children aged 1 month to 10 years of either sex with medium sized VSD (diagnosed by 2D echo) presenting with congestive heart failure
排除标准
- •i.Patients already on enalapril
- •ii.Patients who have already undergone surgical correction of VSD
- •iii.Patients with small and large sized VSD
- •iv.Patients with renal dysfunction or hyperkalemia
- •v.Patients with cardiogenic shock
研究者
相似试验
已完成
不适用
Efficacy of taking Aceclofenac painkiller before root canal treatment on pain after the treatment- A Clinical TrialCTRI/2019/09/021074S Jothi Latha75
已完成
不适用
Retrospective study to determine the effects of acetabular fractureExamination of the quality of life after an acetabular fractureS32.4Fracture of acetabulumDRKS00004762Berufsgenossenschaftliche UnfallklinikKlinik für Unfall- und Wiederherstellungschirurgie derEberhard-Karls-Universität Tübingen58
进行中（未招募）
1 期
A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib TherapyHigh Risk Chronic Lymphocytic LeukemiaMedDRA version: 20.1Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 100000004864EUCTR2015-005317-68-BEAcerta Pharma, BV60
进行中（未招募）
1 期
A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib TherapyHigh Risk Chronic Lymphocytic LeukemiaMedDRA version: 21.0Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 100000004864EUCTR2015-005317-68-GBAcerta Pharma B.V.60
进行中（未招募）
1 期
A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib TherapyHigh Risk Chronic Lymphocytic LeukemiaMedDRA version: 19.0Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 100000004864EUCTR2015-005317-68-ESAcerta Pharma, BV80